Diuretic Comparison Project



Status:Recruiting
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:65 - Any
Updated:2/23/2019
Start Date:June 15, 2016
End Date:April 15, 2023
Contact:Jade Fiotto
Email:Jade.Fiotto@va.gov
Phone:(617) 232-9500

Use our guide to learn which trials are right for you!

CSP #597 - Diuretic Comparison Project

The purpose of this study is to determine whether chlorthalidone is more effective than
hydrochlorothiazide at preventing cardiovascular outcomes in Veterans over age 65 with
hypertension. Both medications are thiazide-type diuretics that have been used for more than
50 years and are considered first-line treatment for hypertension. Patients currently
prescribed hydrochlorothiazide will be randomized to either continue taking
hydrochlorothiazide or to receive chlorthalidone, and followed for major cardiovascular
events, such as myocardial infarction (MI) and stroke. The study will use a new, efficient
and less expensive study design termed 'point of care', in which study operations will be
conducted centrally and patient data will be collected passively through the electronic
medical record.

Over 1 million Veterans are prescribed a thiazide-type diuretic each year; over 95% receive
hydrochlorothiazide, and fewer than 2.5% receive chlorthalidone. Both medications are
thiazide-type diuretics that have been used for more than 50 years and are considered
first-line treatment for hypertension. Indirect evidence has been accumulating, however, that
chlorthalidone may be more effective than hydrochlorothiazide at preventing cardiovascular
events. This will be the first randomized head-to-head comparison of the effectiveness of
these two drugs. The study plans to enroll 13,500 Veterans over 3 years and follow them on
average for 3 years, resulting in a total study duration of 4.5 years. Patients currently
prescribed hydrochlorothiazide will be randomized to either continue taking
hydrochlorothiazide or to receive an equivalent dose of chlorthalidone. The unique 'point of
care' or 'clinically integrated' study design will identify, enroll and follow subjects using
the electronic medical record system and national VA and non-VA databases. The primary
outcome is an event composite consisting of: stroke, myocardial infarction, non-cancer death,
urgent revascularization, and hospitalization for acute congestive heart failure. All patient
care, including the study drug, will continue to be managed by the primary care provider.

Primary Care Providers will also be included as participants in this research study. Adding
providers as subjects will allow us to study the implementation of the point of care protocol
design in addition to the original research question. The study team will collect data on
diuretic management within the study and may contact providers by phone or email to learn
reasons for declining a particular patient or discontinuing a new chlorthalidone order or an
ongoing diuretic prescription.

If cardiovascular events are reduced by even a small amount by chlorthalidone, the public
health effect will be considerable because of the large number of patients who take
diuretics. A randomized trial, now feasible due to the investigators' efficient and
inexpensive design, will provide evidence needed to better inform practice throughout the VA.

Inclusion Criteria:

Veterans who:

- Are over age 65 years

- Are receiving hydrochlorothiazide from the VA pharmacy at a daily dose of 25 or 50 mg

- Have a most recent systolic blood pressure (SBP) in CPRS greater than or equal to 120
mm Hg, with no SBP less than 120 mm Hg recorded in CPRS in the previous 90 days

Primary Care Providers will also be included as participants in this research study.

Exclusion Criteria:

- Impaired decision-making capacity rendering the patient unable to provide informed
consent (i.e., if there is any question during the nurse's EMR chart review that the
individual does not have the ability to make an autonomous decision or the PCP
declines permission to randomize)

- Death expected within 6 months (inferred by PCP permission to randomize)

- K<3.1 meq/L (or K<3.5 meq/L if on digoxin) in the past 90 days

- Na<130 meq/L in the past 90 days

- Known to be enrolled in Medicare Part C (assessed on consent phone call). This
exclusion will only be employed if the investigators determine that sufficient
information from Part C data cannot obtained.
We found this trial at
25
sites
915 North Grand Boulevard
Saint Louis, Missouri 63106
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Baltimore, Maryland 21202
Phone: 857-364-4885
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bay Pines, Florida 33708
Phone: 857-364-4885
?
mi
from
Bay Pines, FL
Click here to add this to my saved trials
Bedford, Massachusetts 01730
Phone: 857-364-4885
?
mi
from
Bedford, MA
Click here to add this to my saved trials
Birmingham, Alabama 35233
Phone: 857-364-4885
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Boston, Massachusetts 02130
Phone: 857-364-6948
?
mi
from
Boston, MA
Click here to add this to my saved trials
Cleveland, Ohio 44106
Phone: 857-364-6948
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Durham, North Carolina 27705
?
mi
from
Durham, NC
Click here to add this to my saved trials
Fargo, North Dakota 58102
?
mi
from
Fargo, ND
Click here to add this to my saved trials
Fayetteville, Arkansas 72703
Phone: 857-364-4885
?
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Gainesville, Florida 32608
Phone: 857-364-4885
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
?
mi
from
Hines, IL
Click here to add this to my saved trials
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
Manchester, New Hampshire 03104
?
mi
from
Manchester, NH
Click here to add this to my saved trials
Memphis, Tennessee 38104
Phone: 617-232-9500
?
mi
from
Memphis, TN
Click here to add this to my saved trials
Milwaukee, Wisconsin 53295
Phone: 857-364-4885
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Minneapolis, Minnesota 55417
Phone: 617-232-9500
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
New York, New York 10010
Phone: 857-364-4885
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Portland, OR
Click here to add this to my saved trials
Saint Cloud, Minnesota 56303
Phone: 857-364-4885
?
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
810 Eastern Avenue
Togus, Maine 04330
?
mi
from
Togus, ME
Click here to add this to my saved trials
Washington, District of Columbia 20422
Phone: 857-364-4885
?
mi
from
Washington,
Click here to add this to my saved trials
West Haven, Connecticut 06516
Phone: 857-364-4885
?
mi
from
West Haven, CT
Click here to add this to my saved trials
?
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
White River Junction, VT
Click here to add this to my saved trials